149 related articles for article (PubMed ID: 34047135)
61. Traditional Chinese Medicine on the Treatment of Coronary Heart Disease in Recent 20 Years.
Gong P; Li Y; Yao C; Guo H; Hwang H; Liu X; Xu Y; Wang X
J Altern Complement Med; 2017 Sep; 23(9):659-666. PubMed ID: 28497986
[TBL] [Abstract][Full Text] [Related]
62. [Assessment of the quality of randomized controlled trials in treating coronary heart disease by Chinese patent medicine].
Jia YL; Huang FY; Zhang SK
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):560-8. PubMed ID: 22803444
[TBL] [Abstract][Full Text] [Related]
63. Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease.
Dong P; Hu H; Guan X; Ung COL; Shi L; Han S; Yu S
Chin Med; 2018; 13():28. PubMed ID: 29946348
[TBL] [Abstract][Full Text] [Related]
64. [Analysis of Diemailing Kudiezi injection use in real world in 7 189 patients with cerebral infarction].
Liao X; Zhang Y; Xie YM; Liu Y; Yi DH; Zhang YL; Chen F
Zhongguo Zhong Yao Za Zhi; 2016 Dec; 41(23):4442-4450. PubMed ID: 28933125
[TBL] [Abstract][Full Text] [Related]
65. [Analysis of clinical application characteristics of Xingnaojing Injection in treating cerebral hemorrhage in real world].
Shi DD; Lyu J; Xie YM; Sun LX; Liu MX; Zhang M
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3511-3517. PubMed ID: 32893538
[TBL] [Abstract][Full Text] [Related]
66. Identification of blood-activating components from Xueshuan Xinmaining Tablet based on the spectrum-effect relationship and network pharmacology analysis.
Tan J; Liu J; Wang H; Zhang Y; Lin H; Wang Z; Si H; Zhang Y; Liu J; Li P; Sun K
RSC Adv; 2020 Mar; 10(16):9587-9600. PubMed ID: 35497256
[TBL] [Abstract][Full Text] [Related]
67. [Retrospective analysis of 2 997 inpatients with skin and soft tissue injuries].
Yang Y; Chu WL; Feng G; Zhang HJ; Hao DF
Zhonghua Shao Shang Za Zhi; 2020 Sep; 36(9):821-829. PubMed ID: 32972067
[No Abstract] [Full Text] [Related]
68. [Effect of integrated Traditional Chinese and Western medicine on immune function in patient of acute cerebral infarction].
Lai Z; Geng X; Wang S
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Jan; 19(1):27-8. PubMed ID: 11783256
[TBL] [Abstract][Full Text] [Related]
69. The Therapeutical Effect of Chinese Medicine for the Treatment of Atherosclerotic Coronary Heart Disease.
Zhang J; Meng H; Zhang Y; Zhang X; Shao M; Li C; Tu P
Curr Pharm Des; 2017; 23(34):5086-5096. PubMed ID: 28782475
[TBL] [Abstract][Full Text] [Related]
70. Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China.
Spatz ES; Wang Y; Beckman AL; Wu X; Lu Y; Du X; Li J; Xu X; Davidson PM; Masoudi FA; Spertus JA; Krumholz HM; Jiang L
Circ Cardiovasc Qual Outcomes; 2018 Mar; 11(3):e004190. PubMed ID: 29848478
[TBL] [Abstract][Full Text] [Related]
71. [Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein IIb/III a receptors in patients with acute coronary syndrome: a randomized controlled trial].
Zhu YF; Luo HM; Deng ZL; Fu DY; Yao W; Dai J
Zhong Xi Yi Jie He Xue Bao; 2012 Mar; 10(3):318-23. PubMed ID: 22409922
[TBL] [Abstract][Full Text] [Related]
72. [Systematic review and Meta-analysis of clinical efficacy and safety of Ginkgo Leaf Tablets in treatment of acute cerebral infarction].
Meng TT; Tian ZY; Xie XL; Li TT; Liu WD; Gao Y
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1537-1546. PubMed ID: 33787152
[TBL] [Abstract][Full Text] [Related]
73. [Clinical application of Xingnaojing Injection in treatment of 11 674 cases of cerebral infarction: a real world study].
Geng HJ; Xie YM; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2329-2334. PubMed ID: 32495589
[TBL] [Abstract][Full Text] [Related]
74. [Study on the hospitalization cost and its influencing factors of imported malaria patients in Guangxi Zhuang Autonomous Region and Yunnan Province].
Xu QL; Lin KM; Yin SQ; Qian MB; Wang DQ; Duan L; Lu SN; Li YX; Xiao N
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Apr; 33(2):154-161. PubMed ID: 34008362
[TBL] [Abstract][Full Text] [Related]
75. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Mao W; Tang S; Zhu Y; Xie Z; Chen W
Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
[TBL] [Abstract][Full Text] [Related]
76. [Evalation of Jingzhi Xiaoban Tablet in Improving Heart Function of Coronary Heart Disease Pa- tients by Doppler Tissue Imaging and Speckle Tracking Imaging Technology].
Wang YA; Yu XJ; Cheng CF; Yang L; Liu F; Zhou MH; Tan Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):399-402. PubMed ID: 27323608
[TBL] [Abstract][Full Text] [Related]
77. [Clinical trial on treatment of acute cerebral infarction with TCM treatment according to syndrome differentiation combining Western medicine by staging].
Cai DF; Yang YK; Gu XX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):789-92. PubMed ID: 17969888
[TBL] [Abstract][Full Text] [Related]
78. Impact of Critical Illness Insurance on the Burden of High-Cost Rural Residents in Central China: An Interrupted Time Series Study.
Li L; Jiang J; Xiang L; Wang X; Zeng L; Zhong Z
Int J Environ Res Public Health; 2019 Sep; 16(19):. PubMed ID: 31547215
[TBL] [Abstract][Full Text] [Related]
79. Outcome and safety assessment of an herbal medicine treatment protocol for yin pattern of acute ischemic stroke.
Huang Y; Guo JW;
Zhong Xi Yi Jie He Xue Bao; 2010 May; 8(5):417-26. PubMed ID: 20456839
[TBL] [Abstract][Full Text] [Related]
80. [Complex network analysis on Shenxiong glucose injection in combined use with Chinese and Western medicine for cerebral infarction in real world study].
Liu H; Xie YM; Zhang Y; Jia PP; Zhuang Y
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2889-2894. PubMed ID: 29139253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
